REIC/Dkk-3 (in-situ)

REIC/Dkk-3 · Momotaro-Gene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REIC/Dkk-3 (in-situ), covering 2013-08-23 to 2013-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer [Phase 1]